1 year survival rate is now at 60%. This is slightly better than Biovex which was about 58%. Oh yes Biovex did a $1b deal. IMO keep on your watch list.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive